hemoglobin based oxygen carrier-201
Biologicalexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2003 (NCT00317512)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Hemoglobin HbASupplementation
HBB supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hemoglobin based oxygen carrier-201
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00479895 | Phase 2 | Apr 1, 2007 | Biopure Corporation |
| NCT00301483 | Phase 2 | Jul 1, 2004 | Biopure Corporation, Wits University |
| NCT00317512 | Phase 2 | Dec 1, 2003 | Biopure Corporation, Radboud University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biopure Corporation | For profit | 3 | 3 | 1 | 2003 |
| Radboud University | Academic/Hospital | 1 | 0 | 1 | 2003 |
| Wits University | Academic/Hospital | 1 | 0 | 1 | 2004 |
3 organizations
Page 1 / 1